Lead Discovery Services
Enzyme Inhibitor Screening Services
- Kinase Inhibitor Screening
- Arginase Inhibitor Assay
- PTP1b Inhibitor Assay
- Monoamine Oxidase Inhibitor Assay
- Acetylcholinesterase Inhibitor Assay
- Aldehyde Dehydrogenase Inhibitor Assay
- Farnesyl Transferase Inhibitor Assay
- Poly(ADP-Ribose) Polymerase (PARP) Inhibitor Assay
- Nitric Oxide Synthase Inhibitor Assay
- Urokinase Inhibitor Assay
Other Enzymes
- Acid Phosphatase
- Aconitase
- Alkaline Phosphatase
- Amylase
- Aspartate Transaminase
- ATP-Citrate Lyase
- Catalase
- Creatine Kinase
- Diamine Oxidase
- Fumarase
- Glucose Oxidase
- Glucose-6-Phosphate Dehydrogenase
- Glutamate Dehydrogenase
- Glutathione Peroxidase
- Glutathione Reductase
- Glutathione S-transferase
- Glyoxalase
- Invertase/Sucrase
- Isocitrate Dehydrogenase
- Lactate Dehydrogenase
- Lipase
- Malate Dehydrogenase
- Mannosidase
- Myeloperoxidase
- Neuraminidase
- Phosphatase
- Phospholipase D
- Pyruvate Kinase
- Sorbitol Dehydrogenase
- Superoxide Dismutase
- Urease
- Xanthine Oxidase
Signal Transduction and Drug Discovery
We routinely determine the test compound’s reactivity with different cell species, phosphorylation kinetics and the IC50 of activation or inhibition of the cellular pathway. Learn more.
Please email or call us at +1-510-782-9988 ext 2 to discuss your service needs.
ADMET
Absorption/Solubility: The solubility of a drug compound plays a significant role in absorption and is an important factor to consider during development. Quantitative measurement of compound solubility is an ideal early test to perform when screening for potential drug candidates. Distribution: Most drugs must pass through membrane barriers to reach their target. We offer quantitative measurement of compound permeability (More details).
- Blood Brain Barrier (BBB) Permeability Inquire
- Gastrointestinal (GI) Permeability Inquire
- Skin Permeability Inquire
Please email or call us at +1-510-782-9988 ext 2 to discuss your service needs.
Mitochondrial Membrane Potential
Select Publications by BioAssay Systems' Scientists
Rommel Mallaria, Elissa Swearingenb, Wei Liu, Arnold Ow, Stephen W. Young and Shu-Gui Huang* (2003) “A Generic High- throughput Screening Assay for Kinases: Protein Kinase A as an Example”. J. Biomol. Screen. 8: 198-204.
Catherine A. Hong, Elissa Swearingen, Rommel Mallari, Xiong Gao, Zhaodan Cao, Anne North, Stephen W. Young and Shu-Gui Huang* (2003) “Development of A High-Throughput Time-Resolved Fluorescence Resonance Energy Transfer Assay for TRAF6 Ubiquitin Polymerization”. Assay and Drug Development Technologies 1: 175-180.
Shu-Gui Huang* (2002) “Development of A High-throughput Screening Assay for Mitochondrial Membrane Potential in Living Cells”. J. Biomol. Screen. 7: 383-389.
Ellyn Farrelly, M. Catherine Amaral, Lisa Marshall and Shu-Gui Huang* (2001) A high-throughput assay for mitochondrial membrane potential in permeabilized yeast cells. Analytical Biochemistry 293(2):269-276.
Tony Smith, John Chan, Donna Oksenberg, Roman Urfer, Dave Wexler, Arnie Ow, Liping Gao, Alanna McAlorum, and Shu-Gui Huang* (2004). A High-Throughput Turbidometric Assay for Screening Inhibitors of Protein Disulfide Isomerase Activity. J. Biomol. Screen. 9(7): 614-620.
David S. Wexler, Liping Gao, Francisco Anderson, Arnold Ow, Laszlo Nadasdi, Alanna McAlorum, Roman Urfer, and Shu-Gui Huang* (2005). “Linking Solubility and Permeability Assays for Maximum Throughput and Reproducibility”. J. Biomol. Screen. 10(4): 383-390.
Shu-Gui Huang (2005) “Progress from HTS to HTL: Current Strategies in Drug Lead Discovery” Review article in Trends in Pharmaceutical Research 1: 5-10.
David S. Wexler, Shu-Gui Huang, Roman Urfer (2004). “Replumbing the Pipeline: A small, biopharmaceutical company’s strategy for integrating lead optimization and ADMET screening”. Current Drug Discovery, May 2004: 35-38.
Songzhu An, Gene Cutler, Jack Jiagang Zhao, Shu-Gui Huang, Hui Tian, Wanbo Li, Lingming Liang, Mike Rich, Amy Bakleh, Juan Du, Jin-Long Chen and Kang Dai (2001) Identification and Characterization of a melanin-concentrating hormone receptor. Proc. Natl. Acad. Sci. 98: 7576-7581.
Shu-Gui Huang, Donna Oksenberg, Roman Urfer (2005). “High-throughput Turbidometric Assay for Screening Inhibitors of Protein Disulfide Isomerase Activity”. US 6,977,142.